These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20478372)

  • 1. Specific aspects of gastro-intestinal transit in children for drug delivery design.
    Bowles A; Keane J; Ernest T; Clapham D; Tuleu C
    Int J Pharm; 2010 Aug; 395(1-2):37-43. PubMed ID: 20478372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.
    Pinto JF
    Int J Pharm; 2010 Aug; 395(1-2):44-52. PubMed ID: 20546856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.
    Varum FJ; Merchant HA; Basit AW
    Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transit of dosage forms through the small intestine.
    Yuen KH
    Int J Pharm; 2010 Aug; 395(1-2):9-16. PubMed ID: 20478371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
    Chuong MC; Christensen JM; Ayres JW
    Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
    Chui J; Tordoff J; Reith D
    Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model.
    Klein S; Stein J; Dressman J
    J Pharm Pharmacol; 2005 Jun; 57(6):709-19. PubMed ID: 15969925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.
    Koziolek M; Grimm M; Becker D; Iordanov V; Zou H; Shimizu J; Wanke C; Garbacz G; Weitschies W
    J Pharm Sci; 2015 Sep; 104(9):2855-63. PubMed ID: 25411065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pediatric drug formulations.
    Nahata MC
    Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Companion animal physiology and dosage form performance.
    Sutton SC
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation strategies for absorption windows.
    Davis SS
    Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal transit and functionality of multiple unit dosage forms.
    Podczeck F
    Int J Pharm; 2010 Aug; 395(1-2):1. PubMed ID: 20452411
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children.
    Kersten E; Barry A; Klein S
    Pharmazie; 2016 Mar; 71(3):122-7. PubMed ID: 27183705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical applications of AC biosusceptometry.
    Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
    Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.